NYSE · ELV
Elevance Health Inc.
Healthcare · Medical - Healthcare Plans
$381.67▼ 1.84% ($7.15)at close
As of 4:00 PM ET
Market cap
$82.77B
P/E
16.76
EPS (TTM)
$22.78
Next earnings
Oct 21, 2026
Valuation
P/E Valuation
Verdict: fairly priced. Price above Bull.
Estimated value / share · Base
$406.39
+6%Price vs. estimate range
Assumption scenarios, not confidence intervals
Bear $381.36, Base $406.39, Bull $381.36; price used $381.67
Bear $381.36, Base $406.39, Bull $381.36; price used $381.67
- P/E multiple
- 17.8×
- Earnings basis
- Trailing EPS
USD · Trailing earnings · Price Oct 1, 8:00 PM UTC
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock rose 20.33% over the last year. Revenue grew 6.27% over the trailing twelve months. Operating margin moved from 4.46% to 3.51%. Free cash flow grew 17.84% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 3.51%. A decisive move in revenue — currently up 6.27% — would be the clearest signal to resolve the ambiguity.
Return analysis
Company profile
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path.
Market multiples
Stock splits
Every 1 shares became 2
Profitability & growth
Standard profitability metrics can be misleading for financial/insurance companies. GAAP requires unrealized investment gains/losses in net income (affecting ROE), and margins are blended across diverse business segments.
Analyst consensus
27
Buy
11
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Oct 21, 2026
Q3 FY26 · EPS est $4.66 · Revenue est $49.3B
View
Institutional Sentiment
Elevance Health Inc. · ELV
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.